| Date Filed | Type | Description |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 05/30/2023 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 03/02/2023 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 700 shares
@ $245.1, valued at
$171.6k
Exercised 700 options
@ $132.3, valued at
$92.6k
|
|
| 02/02/2023 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 700 shares
@ $261.33, valued at
$182.9k
Exercised 700 options
@ $132.3, valued at
$92.6k
|
|
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 710 shares
@ $211.56, valued at
$150.2k
Exercised 710 options
@ $132.3, valued at
$93.9k
|
|
| 09/06/2022 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 4,910 shares
@ $225.9776, valued at
$1.1M
Exercised 4,910 options
@ $101.8, valued at
$499.8k
|
|
| 07/11/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2021 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Granted 3,230 options
@ $183.98, valued at
$594.3k
Granted 1,080 restricted stock units
@ $0 |
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2020 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Gifted 10,004 shares
@ $0 |
|
| 09/04/2020 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 20,525 shares
@ $111.2157, valued at
$2.3M
Sold 7,893 shares
@ $111.2256, valued at
$877.9k
Exercised 7,893 options to buy
@ $20.08, valued at
$158.5k
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2020 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 2,821 shares
@ $0 |
|
| 03/27/2020 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Disposed/sold 15,000 shares
@ $90.54, valued at
$1.4M
Exercised 15,000 options to buy
@ $48.11, valued at
$721.7k
|
|
| 03/24/2020 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Disposed/sold 6,000 shares
@ $83.95, valued at
$503.7k
Exercised 6,000 options to buy
@ $54.77, valued at
$328.6k
|
|
| 03/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2020 |
4/A
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Disposed/sold 1,000 shares
@ $115.04, valued at
$115k
Exercised 1,000 options to buy
@ $54.77, valued at
$54.8k
|
|
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2019 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 5,736 shares
@ $0 |
|
| 05/09/2019 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 2,135 shares
@ $49.41, valued at
$105.5k
Exercised 7,893 options to buy
@ $13.37, valued at
$105.5k
|
|
| 03/04/2019 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Disposed/sold 1,000 shares
@ $126.84, valued at
$126.8k
Exercised 1,000 options to buy
@ $54.77, valued at
$54.8k
|
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Disposed/sold 1,000 shares
@ $107.65, valued at
$107.7k
Exercised 1,000 options to buy
@ $54.77, valued at
$54.8k
|
|
| 12/04/2018 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Disposed/sold 1,000 shares
@ $119.53, valued at
$119.5k
Exercised 1,000 options to buy
@ $54.77, valued at
$54.8k
|
|
|